Skip to content
10-Q

Quarterly Report

Rapid Therapeutic Science Laboratories, Inc.

0001393905-22-000151

← back to feed
Filed
May 11, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 11, 2022 7.75M sh
Cash And Equivalents Q1 2022 · Mar 31, 2022 $32.99K
Cash And Equivalents Q1 2022 · Dec 31, 2021 $192.48K
Stockholders Equity Q1 2022 · Mar 31, 2022 −$2.94M
Stockholders Equity Q1 2022 · Dec 31, 2021 −$1.38M
Current Liabilities Q1 2022 · Mar 31, 2022 $5.12M
Current Liabilities Q1 2022 · Dec 31, 2021 $3.05M
Total Liabilities Q1 2022 · Mar 31, 2022 $5.63M
Total Liabilities Q1 2022 · Dec 31, 2021 $3.58M
Current Assets Q1 2022 · Mar 31, 2022 $279.3K
Current Assets Q1 2022 · Dec 31, 2021 $419.16K
Total Assets Q1 2022 · Mar 31, 2022 $2.69M
Total Assets Q1 2022 · Dec 31, 2021 $2.2M
Net Income Q1 2022 · Mar 31, 2022 −$1.58M
Net Income Q1 2022 · Mar 31, 2021 −$533.75K
Capex Q1 2022 · Mar 31, 2021 $19.78K
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$524.37K
Eps Basic Q1 2022 · Mar 31, 2021 −$0.07
Sga Expense Q1 2022 · Mar 31, 2021 $501.92K
Revenue Q1 2022 · Mar 31, 2021 $0